Caveolin-1 Expression Ameliorates Nephrotic Damage in a Rabbit Model of Cholesterol-Induced Hypercholesterolemia

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Caveolin-1 (CAV-1) is crucial for vesicular transport, signal transduction, tumor progression, and cholesterol homeostasis.
• Cholesterol-induced hypercholesterolemia leads to dyslipidemia, oxidative stress, and mitochondrial dysfunction.
• Cyclophilin A (CypA) plays a role in ROS production and oxidative stress.

Purpose of the Study:

• To investigate the role of CAV-1 in improving dyslipidemia, inhibiting ROS production, and mitigating oxidative stress in hypercholesterolemia.
• To determine if CAV-1 can prevent mitochondrial dysfunction and attenuate oxidative stress responses in a rabbit model of hypercholesterolemia.

Main Methods:

• Hypercholesterolemic rabbits were intravenously administered antenapedia-CAV-1 (AP-CAV-1) peptide for 2 weeks.
• Assessed CAV-1 and CypA expression levels.
• Evaluated lipid peroxidation, mitochondrial morphology and function, oxidative damage markers, antioxidant enzyme expression, and apoptotic cell death.

Main Results:

• AP-CAV-1 treatment significantly enhanced CAV-1 expression and inhibited CypA expression.
• Dyslipidemia was improved, with reduced neutral lipid peroxidation and attenuated hypercholesterolemia-induced mitochondrial changes.
• CAV-1 preserved mitochondrial respiratory function, reduced oxidative damage, enhanced antioxidant enzyme expression, and suppressed apoptotic cell death.

Conclusions:

• CAV-1 plays a critical role in inhibiting CypA-mediated ROS production and improving dyslipidemia.
• CAV-1 maintains mitochondrial function and suppresses oxidative stress responses in hypercholesterolemia.
• CAV-1 treatment offers protective effects against cell death in hypercholesterol-affected renal organs.